Prospective Study on Swallowing/Breathing Interactions in Severe Guillain Barre Syndrome.
NCT ID: NCT01024088
Last Updated: 2014-09-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2008-03-31
2012-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predictive Value of Neuromuscular Ultrasound of Cranial Nerves in Guillain-Barré Syndrome
NCT06200454
Early and Late Prognosis in Patients With Guillain-Barre Syndrome
NCT06041451
Firm Observational Clinical Unicenter Study on Guillain Barré Syndrome
NCT04829526
Living With Guillain-Barré Syndrome as Children.
NCT06940908
Peripheral Nerve Ultrasound for Diagnosis and Prognosis of Guillain-Barre Syndrome
NCT04053452
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Method: longitudinal observational and in a one center study. The respiratory impairment will be estimated by the measure of the vital capacity, maximal respiratory pressures and of the debit of cough. The existence of a bulbar infringement will be sought by the measure of the force of the tongue, an objective measure of gulp performances and a polysomnographic recording.
Criterion of selection: patient admitted in ICU with GBS and respiratory risk. Number of patients, centre: 40 patients admitted in the intensive care unit of the hospital RAYMOND POINCARE and 20 controls.
Duration of the study: 24 months Perspectives: better anticipate acute respiratory failure and the indication of an invasive ventilation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GBS PATIENT
No interventions assigned to this group
CONTROL
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Presenting a risk of mechanical ventilation(breakdown): presence of 2 among the following 5 criteria
* Deficit evolving for less than 7 days
* Impossibility to stand up
* Impossibility to raise the head
* ineffective Cough
* Vital capacity\< 60 %
Exclusion Criteria
* Respiratory distress syndrome and intubation at admission buccal dental lesions
* Not membership to a regime of Social Security (beneficiary or legal successor)
* Patient under guardianship or custody
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Orlikowski, PH
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
hôpital Raymond Poincaré
Garches, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P061016 -CRC 06040
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.